An interventional study of Therapeutic educational consolidation program in Phase 3 of cardiac rehabilitation associating a patient & caregiver partnership and Teleconsultation at 2 months in Myocardial Infarction, sponsored by Centre Hospitalier Universitaire de Nīmes. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-23.
Sponsored by Centre Hospitalier Universitaire de Nīmes · Not applicable, Interventional, and Supportive care
Following myocardial infarction, cardiac rehabilitation has undeniable benefits on criteria such as cardiovascular mortality and coronary recurrence. Cardiac rehabilitation consists of 3 phases:
Various interventions (booklets, applications, activity programs, motivational talks led by healthcare professionals have been tested and compared with the usual care in Phase 3 cardiac rehabilitation. An effect seems to exist on the level of physical activity reported, but with a significant evaluation bias. This study aims to use accelerometry to evaluate the 6-month efficacy of the therapeutic education program for consolidation in phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver on moderate-to-sustained physical activity (> 3 METs) in coronary patients on Phase 3 of cardiac rehabilitation compared with usual rehabilitation management.
Following myocardial infarction, cardiac rehabilitation has shown undeniable benefits on strong criteria such as cardiovascular mortality and coronary recurrence. Cardiac rehabilitation consists of 3 phases:
The importance of phase 2 of cardiac rehabilitation is particularly emphasized and is the subject of recommendations by learned societies. The aim is to re-train the patient under paramedical and medical supervision, and to induce behavioral changes through specific therapeutic education. Exercise re-training aims to increase the patient's cardiorespiratory functional capacity and their ability to do physical activity of moderate-to-sustained intensity. One of the most commonly used units to calculate the intensity of physical activity is the Metabolic Equivalent of Task (MET). The higher the intensity of the activity, the higher the number of METs. Physical activity of at least moderate intensity, as recommended in the long-term care of coronary patients corresponds to 3 METs. The therapeutic objective by international recommendations, and explained to patients during phase 2 CR, is to achieve 150 minutes a week of moderate-to-sustained physical activity (3 METs or more). However, only 20% to 40% of coronary patients remain physically active at 6 months or 1 year, which means that the effects of Phase 2 cardiac rehabilitation are not maintained. Managing to maintain at least a moderate level of physical activity after phase 2 of CR, is a major objective.
Various interventions (booklets, applications, activity programs, motivational talks led by healthcare professionals have been tested and compared with the usual care in Phase 3 cardiac rehabilitation. An effect seems to exist on the level of physical activity reported, but with a significant evaluation bias. Objective, validated measures of physical activity such as accelerometry have not proved their long-term efficacy (6 months being the classically explored endpoint). An intervention establishing a patient-centered relationship and cognitive-behavioral elements would seem to be a perspective of choice to be explored, therapeutic education having been little explored in phase 3 of cardiac rehabilitation and in the long term. To address some of the barriers identified in qualitative studies, the joint participation of a "patient partner" would seem to of interest. The PP is a patient who has acquired knowledge of their disease over time, through experience and experience and therapeutic education. They encourage dialogue between care teams and patients, facilitating patients' self-expression, and contributes to a better understanding of the discourse.
The hypothesis is that a therapeutic educational consolidation program, involving a "patient partner" associated with a health professional, will increase the level of physical activity of coronary patients in Phase 3 of cardiac rehabilitation.
The main objective of this study is to use accelerometry to evaluate the 6-month efficacy of the therapeutic education program for consolidation in phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver on the level of moderate to sustained physical activity (> 3 METs) in coronary patients on Phase 3 of cardiac rehabilitation compared with usual rehabilitation management.
2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.
This study's enrollment of 84 is below the median of 148 across 1,595 interventional studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →Centre Hospitalier Universitaire de Nīmes is the lead sponsor of 587 studies on the registry; 96 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients in Phase 3 of cardiac rehabilitation, undergoing the usual care provided.
Patients in Phase 3 of cardiovascular rehabilitation, following a therapeutic educational program for consolidation ("patient partner" and a caregiver) as well as the usual care provided.
Other: Therapeutic educational consolidation program in Phase 3 of cardiac rehabilitation associating a patient & caregiver partnership · Other: Teleconsultation at 2 months · Other: Teleconsultation at 4 months · Other: Remote group education workshop · Other: Administration of self-questionnaires: IPAQ, EMAPS, the Exercise Confidence Survey, EQ-5D-5L and the Mediterranean diet adherence score. · Diagnostic Test: 6-minute walk test and administers the modified Borg scale at its conclusion. · Diagnostic Test: Biological check-up · Device: Accelerometer · Other: Administration of a logbook
In the experimental group, patients benefit from the usual management as part of the phase 2 post-CR follow-up, with the provision of an information booklet on the benefits of physical activity, and a telephone contact in the event of any questions. In addition, they benefit from the "Consolidation therapeutic education program in phase 3 of CR associating a patient \& caregiver partnership, which consists of two teleconsultation sessions at 2 and 4 months, followed by a remote group education workshop co-facilitated by the patient and caregiver partnership at 5 months. Discussions during teleconsultations will be recorded to identify the main barriers to physical activity mentioned by patients, and the responses provided by the healthcare professional-peer helper pair during the therapeutic education sessions.
Discussions during teleconsultations will be recorded to identify the main barriers to physical activity mentioned by patients, and the responses provided by the healthcare professional-peer helper pair during the therapeutic education sessions.
Discussions during teleconsultations will be recorded to identify the main barriers to physical activity mentioned by patients, and the responses provided by the healthcare professional-peer helper pair during the therapeutic education sessions.
This remote workshop will be co-facilitated by the patient and caregiver partnership at 5 months
Patients are then randomly assigned to either the control group (usual management) or the experimental group (management with Patient and Caregiver partnership).
What is a modified Borg scale? The Modified Borg Dyspnea Scale is a 0 to 10 rated numerical score used to measure dyspnea as reported by the patient during submaximal exercise and is routinely administered following a six-minute walking test, one of the most common and frequently used measures to assess disease severity in patients with pulmonary arterial hypertension. Upon conclusion of the 6-minute walking test, the modified Borg scale will be recorded.
This check-up includes total cholesterol, LDL, HDL, triglycerides, HbA1c.
An accelerometer is given to the patient, with instructions to wear it for 7 days following the visit (it will then be returned by post).Pre-stamped "bubble" envelopes are given to the patient to return their accelerometer to the measurement points specified in the follow-up.
The patient is given a logbook for daily monitoring of non-measurable physical activities, treatments and medical procedures carried out, as well as any intercurrent events.
Moderate-to-sustained physical activity in the Experimental Group
The accelerometer will be used to evaluate the 6-month efficacy of the therapeutic educational program for consolidation in Phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver and its affect on the level of moderate-to-sustained physical activity (\> 3 METs) in coronary patients in Phase 3 of cardiac rehabilitation compared with usual rehabilitation management. The amount of moderate-to-sustained physical activity (\> 3 METs) will be measured in minutes per week.
Time frame: Month 6
Moderate-to-sustained physical activity in Controls
The accelerometer will be used to evaluate the 6-month efficacy of the therapeutic educational program for consolidation in Phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver and its affect on the level of moderate-to-sustained physical activity (\> 3 METs) in coronary patients in Phase 3 of cardiac rehabilitation compared with usual rehabilitation management. The amount of moderate-to-sustained physical activity (\> 3 METs) will be measured in minutes per week.
Time frame: Month 6
Moderate-to-sustained physical activity in the Experimental Group
The amount of moderate-to-sustained physical activity (\> 3 METs) will be measured with the accelerometer in minutes per week.
Time frame: Month 3
Moderate-to-sustained physical activity in Controls
The amount of moderate-to-sustained physical activity (\> 3 METs) will be measured with the accelerometer in minutes per week.
Time frame: Month 3
Number of steps taken per week in the Experimental Group
Number of steps taken per week recorded by the accelerometer
Time frame: Month 0
Number of steps taken per week in the Experimental Group
Number of steps taken per week recorded by the accelerometer
Time frame: Month 3
Number of steps taken per week in the Experimental Group
Number of steps taken per week recorded by the accelerometer
Time frame: Month 6
Number of steps taken per week in Controls
Number of steps taken per week recorded by the accelerometer
Time frame: Month 0
Number of steps taken per week in Controls
Number of steps taken per week recorded by the accelerometer
Time frame: Month 3
Number of steps taken per week in Controls
Number of steps taken per week recorded by the accelerometer
Time frame: Month 6
Time spent sitting/lying down per week in the Experimental Group
Time spent sitting/lying down per week recorded by the accelerometer
Time frame: Month 0
Time spent sitting/lying down per week in the Experimental Group
Time spent sitting/lying down per week recorded by the accelerometer
Time frame: Month 3
Time spent sitting/lying down per week in the Experimental Group
Time spent sitting/lying down per week recorded by the accelerometer
Time frame: Month 6
Time spent sitting/lying down per week in Controls
Time spent sitting/lying down per week recorded by the accelerometer
Time frame: Month 0
Time spent sitting/lying down per week in Controls
Time spent sitting/lying down per week recorded by the accelerometer
Time frame: Month 3
Time spent sitting/lying down per week in Controls
Time spent sitting/lying down per week recorded by the accelerometer
Time frame: Month 6
International Physical Activity Questionnaire Score in the Experimental Group
The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
Time frame: Month 0
International Physical Activity Questionnaire Score in the Experimental Group
The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
Time frame: Month 3
International Physical Activity Questionnaire Score in the Experimental Group
The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
Time frame: Month 6
International Physical Activity Questionnaire Score in Controls
The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
Time frame: Month 0
International Physical Activity Questionnaire Score in Controls
The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
Time frame: Month 3
International Physical Activity Questionnaire Score in Controls
The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
Time frame: Month 6
Blood pressure in the Experimental Group
mm Hg
Time frame: Month 0
Blood pressure in the Experimental Group
mm Hg
Time frame: Month 3
Blood pressure in the Experimental Group
mm Hg
Time frame: Month 6
Blood pressure in Controls
mm Hg
Time frame: Month 0
Blood pressure in Controls
mm Hg
Time frame: Month 3
Blood pressure in Controls
mm Hg
Time frame: Month 6
Modified Borg score in the Experimental Group
The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
Time frame: Month 0
Modified Borg score in the Experimental Group
The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
Time frame: Month 3
Modified Borg score in the Experimental Group
The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
Time frame: Month 6
Modified Borg score in Controls
The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
Time frame: Month 0
Modified Borg score in Controls
The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
Time frame: Month 3
Modified Borg score in Controls
The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
Time frame: Month 6
Abdominal circumference in the Experimental Group
In cm
Time frame: Month 0
Abdominal circumference in the Experimental Group
In cm
Time frame: Month 3
Abdominal circumference in the Experimental Group
In cm
Time frame: Month 6
Abdominal circumference in Controls
In cm
Time frame: Month 0
Abdominal circumference in Controls
In cm
Time frame: Month 3
Abdominal circumference in Controls
In cm
Time frame: Month 6
Aerobic capacity in the Experimental Group
Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
Time frame: Month 0
Aerobic capacity in the Experimental Group
Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
Time frame: Month 3
Aerobic capacity in the Experimental Group
Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
Time frame: Month 6
Aerobic capacity in Controls
Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
Time frame: Month 0
Aerobic capacity in Controls
Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
Time frame: Month 3
Aerobic capacity in Controls
Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
Time frame: Month 6
Cholesterol in the Experimental Group
mg/dL
Time frame: Month 0
Cholesterol in the Experimental Group
mg/dL
Time frame: Month 3
Cholesterol in the Experimental Group
mg/dL
Time frame: Month 6
Cholesterol in Controls
mg/dL
Time frame: Month 0
Cholesterol in Controls
mg/dL
Time frame: Month 3
Cholesterol in Controls
mg/dL
Time frame: Month 6
Low-density lipoprotein in the Experimental Group
mg/dL
Time frame: Month 0
Low-density lipoprotein in the Experimental Group
mg/dL
Time frame: Month 3
Low-density lipoprotein in the Experimental Group
mg/dL
Time frame: Month 6
Low-density lipoprotein in Controls
mg/dL
Time frame: Month 0
Low-density lipoprotein in Controls
mg/dL
Time frame: Month 3
Low-density lipoprotein in Controls
mg/dL
Time frame: Month 6
High-density lipoprotein in the Experimental Group
mg/dL
Time frame: Month 0
High-density lipoprotein in the Experimental Group
mg/dL
Time frame: Month 3
High-density lipoprotein in the Experimental Group
mg/dL
Time frame: Month 6
High-density lipoprotein in Controls
mg/dL
Time frame: Month 0
High-density lipoprotein in Controls
mg/dL
Time frame: Month 3
High-density lipoprotein in Controls
mg/dL
Time frame: Month 6
Triglycerides in the Experimental Group
mg/dL
Time frame: Month 0
Triglycerides in the Experimental Group
mg/dL
Time frame: Month 3
Triglycerides in the Experimental Group
mg/dL
Time frame: Month 6
Triglycerides in Controls
mg/dL
Time frame: Month 0
Triglycerides in Controls
mg/dL
Time frame: Month 3
Triglycerides in Controls
mg/dL
Time frame: Month 6
Blood glucose levels in the Experimental Group
mg/dL
Time frame: Month 0
Blood glucose levels in the Experimental Group
mg/dL
Time frame: Month 3
Blood glucose levels in the Experimental Group
mg/dL
Time frame: Month 6
Blood glucose levels in Controls
mg/dL
Time frame: Month 0
Blood glucose levels in Controls
mg/dL
Time frame: Month 3
Blood glucose levels in Controls
mg/dL
Time frame: Month 6
Compliance with medication in the Experimental Group
YES/NO
Time frame: Month 0
Compliance with medication in the Experimental Group
YES/NO
Time frame: Month 3
Compliance with medication in the Experimental Group
YES/NO
Time frame: Month 6
Compliance with medication in Controls
YES/NO
Time frame: Month 0
Compliance with medication in Controls
YES/NO
Time frame: Month 3
Compliance with medication in Controls
YES/NO
Time frame: Month 6
Motivation for doing physical activity in the Experimental Group
The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
Time frame: Month 0
Motivation for doing physical activity in the Experimental Group
The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
Time frame: Month 3
Motivation for doing physical activity in the Experimental Group
The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
Time frame: Month 6
Motivation for doing physical activity in Controls
The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
Time frame: Month 0
Motivation for doing physical activity in Controls
The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
Time frame: Month 3
Motivation for doing physical activity in Controls
The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
Time frame: Month 6
Exercise Confidence Survey in the Experimental Group
French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
Time frame: Month 0
Exercise Confidence Survey in the Experimental Group
French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
Time frame: Month 3
Exercise Confidence Survey in the Experimental Group
French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
Time frame: Month 6
Exercise Confidence Survey in Controls
French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
Time frame: Month 0
Exercise Confidence Survey in Controls
French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
Time frame: Month 3
Exercise Confidence Survey in Controls
French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
Time frame: Month 6
Mediterranean diet adherence test in the Experimental Group
The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
Time frame: Month 0
Mediterranean diet adherence test in the Experimental Group
The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
Time frame: Month 3
Mediterranean diet adherence test in the Experimental Group
The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
Time frame: Month 6
Mediterranean diet adherence test in Controls
The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
Time frame: Month 0
Mediterranean diet adherence test in Controls
The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
Time frame: Month 3
Mediterranean diet adherence test in Controls
The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
Time frame: Month 6
Understanding barriers to motivation: Experimental group
The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
Time frame: Month 0
Understanding barriers to motivation: Experimental group
The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
Time frame: Month 3
Understanding barriers to motivation: Experimental group
The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
Time frame: Month 6
Understanding barriers to motivation in Controls
The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
Time frame: Month 0
Understanding barriers to motivation in Controls
The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
Time frame: Month 3
Understanding barriers to motivation in Controls
The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
Time frame: Month 6
Plan to share: Yes — Anonymized individual-level data, including accelerometry recordings and questionnaire responses
Supporting information: Icf
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Nīmes